Phase I trial of S-1 every other day in combination with gemcitabine/cisplatin for inoperable biliary tract cancer
Crossref DOI link: https://doi.org/10.1007/s00280-014-2636-0
Published Online: 2014-11-25
Published Print: 2015-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Uwagawa, Tadashi
Sakamoto, Taro
Abe, Kyohei
Okui, Norimitsu
Hata, Daigo
Shiba, Hiroaki
Futagawa, Yasuro
Aiba, Keisuke
Yanaga, Katsuhiko
Text and Data Mining valid from 2014-11-25